Literature DB >> 29987598

American Society of Breast Surgeons' Practice Patterns After Publication of the SSO-ASTRO-ASCO DCIS Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation.

Sarah M DeSnyder1, Kelly K Hunt2, Wenli Dong3, Benjamin D Smith4, Meena S Moran5, Mariana Chavez-MacGregor6, Yu Shen3, Henry M Kuerer2, Anthony Lucci2.   

Abstract

BACKGROUND: The SSO-ASTRO-ASCO consensus guideline on margins for breast-conserving surgery with whole breast irradiation in ductal carcinoma in situ (DCIS) recommended a 2-mm margin. We sought to determine the impact of guideline publication on clinician practice.
METHODS: A total of 3081 members of the American Society of Breast Surgeons (ASBrS) received a survey. Respondents' clinical practice type and duration, guideline familiarity, and margin width preferences before and after publication were assessed. Clinical practice pattern differences before and after publication were investigated using McNemar's test.
RESULTS: A total of 767 (24.9%) of those surveyed responded. Most (92.4%) indicated guideline familiarity. Of those familiar, re-excision preference for DCIS and a positive margin remained the same before (94.4%) and after (94.3%) publication (McNemar's test p = 1.0). Following publication, surgeons were more likely to avoid re-excision to achieve margins wider than 2-mm (82.3% pre versus 87.5% post, p = 0.002). More surgeons performed re-excision for a close margin with pure DCIS (25.9% pre versus 36.5% post, p < 0.001) and with DCIS with microinvasion (DCIS-M) (40.7% pre versus 52.3% post, p < 0.001). For patients with invasive disease with extensive intraductal component (EIC) and a close margin, preference to avoid re-excision was similar (51.2% per versus 55.2% post, p = 0.071).
CONCLUSION: Since guideline publication, surgeons are less likely to perform re-excision to obtain a margin greater than 2-mm and more likely to perform re-excision to obtain a 2-mm margin for both pure DCIS and DCIS-M. Preference to avoid re-excision with a close margin and EIC was similar before and after publication.

Entities:  

Mesh:

Year:  2018        PMID: 29987598     DOI: 10.1245/s10434-018-6580-9

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

Review 1.  Ductal carcinoma in situ of breast: update 2019.

Authors:  Sunil S Badve; Yesim Gökmen-Polar
Journal:  Pathology       Date:  2019-08-28       Impact factor: 5.306

2.  Effect of Surgeon Factors on Long-Term Patient-Reported Outcomes After Breast-Conserving Therapy in Older Breast Cancer Survivors.

Authors:  Benjamin D Smith; Xiudong Lei; Kevin Diao; Ying Xu; Yu Shen; Grace L Smith; Sharon H Giordano; Sarah M DeSnyder; Kelly K Hunt; Mediget Teshome; Reshma Jagsi; Simona F Shaitelman; Susan K Peterson; Cameron W Swanick
Journal:  Ann Surg Oncol       Date:  2020-01-08       Impact factor: 5.344

Review 3.  A review of studies on omitting surgery after neoadjuvant chemotherapy in breast cancer.

Authors:  Kexin Feng; Ziqi Jia; Gang Liu; Zeyu Xing; Jiayi Li; Jiaxin Li; Fei Ren; Jiang Wu; Wenyan Wang; Jie Wang; Jiaqi Liu; Xiang Wang
Journal:  Am J Cancer Res       Date:  2022-08-15       Impact factor: 5.942

4.  Predictors of Reexcision following Breast-Conserving Surgery for Ductal Carcinoma In Situ.

Authors:  Leslie R Lamb; Sarah Mercaldo; Tawakalitu O Oseni; Manisha Bahl
Journal:  Ann Surg Oncol       Date:  2020-09-10       Impact factor: 5.344

5.  Adoption of SSO-ASTRO Margin Guidelines for Ductal Carcinoma in Situ: What Is the Impact on Use of Additional Surgery?

Authors:  Anita Mamtani; Anya Romanoff; Raymond Baser; Alain Vincent; Monica Morrow; Mary L Gemignani
Journal:  Ann Surg Oncol       Date:  2020-06-04       Impact factor: 5.344

6.  Hypofractionation and Concomitant Boost in Ductal Carcinoma In Situ (DCIS): Analysis of a Prospective Case Series with Long-Term Follow-Up.

Authors:  Domenico Cante; Marina Paolini; Cristina Piva; Edoardo Petrucci; Lorenzo Radici; Silvia Ferrario; Guido Mondini; Silvia Bagnera; Maria Rosa La Porta; Pierfrancesco Franco
Journal:  Life (Basel)       Date:  2022-06-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.